NCCN Task Force report: optimizing treatment of advanced renal cell carcinoma with molecular targeted therapy. Academic Article uri icon

Overview

abstract

  • The outcome of patients with metastatic renal cell carcinoma has been substantially improved with administration of the currently available molecularly targeted therapies. However, proper selection of therapy and management of toxicities remain challenging. NCCN convened a multidisciplinary task force panel to address the clinical issues associated with these therapies in attempt to help practicing oncologists optimize patient outcomes. This report summarizes the background data presented at the task force meeting and the ensuing discussion.

publication date

  • February 1, 2011

Research

keywords

  • Carcinoma, Renal Cell
  • Kidney Neoplasms
  • Molecular Targeted Therapy

Identity

PubMed Central ID

  • PMC4659363

Scopus Document Identifier

  • 79952784860

PubMed ID

  • 21335444

Additional Document Info

volume

  • 9 Suppl 1